Insufficient scRNA-seq data for expression of NLRP4 at single-cell level.
Insufficient scRNA-seq data for expression of NLRP4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 62% | 8.69 | 149 / 241 | 0% | 0 | 0 / 0 |
brain | 36% | 6.64 | 945 / 2642 | 13% | 0.28 | 94 / 705 |
lymph node | 0% | 0 | 0 / 0 | 45% | 20.07 | 13 / 29 |
peripheral blood | 37% | 13.22 | 340 / 929 | 0% | 0 | 0 / 0 |
ovary | 18% | 10.98 | 32 / 180 | 9% | 0.37 | 37 / 430 |
lung | 17% | 0.96 | 97 / 578 | 5% | 0.25 | 53 / 1155 |
skin | 12% | 0.73 | 219 / 1809 | 8% | 0.66 | 39 / 472 |
intestine | 17% | 2.17 | 168 / 966 | 2% | 0.22 | 13 / 527 |
thymus | 14% | 2.92 | 92 / 653 | 1% | 0.03 | 9 / 605 |
blood vessel | 15% | 1.08 | 202 / 1335 | 0% | 0 | 0 / 0 |
breast | 15% | 0.87 | 67 / 459 | 0% | 0.01 | 4 / 1118 |
esophagus | 7% | 0.44 | 108 / 1445 | 7% | 0.42 | 12 / 183 |
pancreas | 9% | 0.56 | 28 / 328 | 4% | 0.19 | 7 / 178 |
prostate | 12% | 2.26 | 30 / 245 | 0% | 0.00 | 1 / 502 |
bladder | 10% | 0.43 | 2 / 21 | 3% | 0.74 | 13 / 504 |
adrenal gland | 10% | 0.56 | 27 / 258 | 0% | 0.00 | 1 / 230 |
uterus | 9% | 0.39 | 15 / 170 | 2% | 0.22 | 8 / 459 |
stomach | 4% | 0.16 | 15 / 359 | 5% | 0.19 | 15 / 286 |
liver | 6% | 0.27 | 14 / 226 | 3% | 0.14 | 13 / 406 |
muscle | 8% | 0.47 | 64 / 803 | 0% | 0 | 0 / 0 |
adipose | 8% | 0.46 | 95 / 1204 | 0% | 0 | 0 / 0 |
kidney | 7% | 0.45 | 6 / 89 | 1% | 0.01 | 6 / 901 |
heart | 6% | 0.26 | 48 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0006954 | Biological process | inflammatory response |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | NLRP4 |
Protein name | NLR family pyrin domain containing 4 NACHT, LRR and PYD domains-containing protein 4 (Cancer/testis antigen 58) (CT58) (PAAD and NACHT-containing protein 2) (PAN2) (PYRIN and NACHT-containing protein 2) (PYRIN-containing APAF1-like protein 4) (PYPAF4) (Ribonuclease inhibitor 2) |
Synonyms | NALP4 PAN2 RNH2 PYPAF4 |
Description | FUNCTION: May be involved in inflammation and recognition of cytosolic pathogen-associated molecular patterns (PAMPs) not intercepted by membrane-bound receptors. Acts as a negative regulator of the type I interferon signaling pathway by serving as an adapter to promote DTX4-mediated ubiquitination of activated TBK1, and its subsequent degradation. Suppresses NF-kappaB induction by the cytokines TNFA and IL1B, suggesting that it operates at a point of convergence in these two cytokine signaling pathways. . |
Accessions | ENST00000587891.5 [Q96MN2-3] Q96MN2 K7ES09 ENST00000589437.1 ENST00000301295.11 [Q96MN2-1] ENST00000587464.1 K7ESK5 |